To evaluate the value of autofluorescence bronchoscopy for diagnosis of lung cancer in patients with high risk factors. Subjects and methods: The study was a prospective, cross-sectional, non-randomized trial at the National Lung Institute in the period from October 2016 to December 2018. | The value of autofluorescence bronchoscopy for diagnosis of lung cancer in patients with high risk factors